CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, a medical technology company focused on advancing treatments for patients suffering from thromboembolic disease, today announced that initial patients have been enrolled in the ADAPT 2.0 Clinical Study, a prospective, multi-center, open-label, observational study evaluating the effectiveness, safety and clinical outcomes of the ADAPT 2.0 technique using the Zoom Stroke System to treat patients with acute ischemic stroke. “This study is designe
Tag: stroke
XYRA Announces Issuance of US Patent to Reduce the Risk of Heart Failure or Strokes by Reducing the Number and Duration of Atrial Fibrillations
LOS ALTOS, Calif., March 4, 2026 /PRNewswire/ — XYRA LLC announces that the US Patent and Trademark Office (USPTO) has issued a patent (No. 12,551,706) protecting the use of dose adjusted budiodarone for the treatment of atrial fibrillation (AF), with monitoring to correspondingly reduce…
LRS SECURES IDE TO STUDY ITS THERMOSUIT COOLING DEVICE IN A PIVOTAL TRIAL OF ISCHEMIC STROKE PATIENTS
ALEXANDRIA, La., March 2, 2026 /PRNewswire/ — Life Recovery Systems (LRS) has received an Investigational Device Exemption (IDE) from the US Food and Drug Administration (FDA) for testing of the ThermoSuit System (TSS) in a pivotal trial of ischemic stroke patients. The previous SISCO…
RapidAI Highlights Research Depth and Industry Leadership at ISC 2026 With 28 Clinical Abstracts
New clinical data show AI-driven gains in aneurysm growth detection, stroke interpretation accuracy, and radiology workflow efficiency across enterprise imaging environments. SAN MATEO, CA (February 4, 2026) – RapidAI, the pioneer of deep clinical AI and global leader in enterprise imaging, today announced details of 28 scientific abstracts accepted at the International Stroke Conference (ISC) […]
Imperative Care Secures FDA Clearance and Initial Cases of the Zoom 7X Catheter, the Newest Innovation in Ischemic Stroke Treatment
CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance and first patient cases with the latest advancement in ischemic stroke treatment – the novel Zoom 7X Catheter for aspiration thrombectomy procedures. The newest addition to the company’s comprehensive Zoom Stroke System, the Zoom 7X Catheter […]
Philips launches intelligent 3D imaging in Europe to empower faster stroke care, helping physicians save time, brain, and lives
Demonstrated at LINNC Paris 2025, the company’s latest release of SmartCT delivers fast, intelligent 3D imaging in the Angio suite — helping physicians act with greater speed and confidence during a range of critical neurovascular procedures
Imperative Care Launches its Next Innovation to Elevate Ischemic Stroke Treatment and Announces First Patients Treated with Continuous Dual Aspiration Technique
CAMPBELL, Calif. – Imperative Care, Inc. today announced the Zoom Stroke System has been further expanded with the launch of the Zoom DuoPort technology, which allows physicians to use the novel Continuous Dual Aspiration Technique (CDAT) on two Zoom Aspiration Catheters simultaneously from a single vacuum source. CDAT empowers physicians with enhanced […]
Stroke Patients Discharged from Hospital Sooner when Administered Revalesio’s RNS60; New Statistically Significant Finding from Revalesio’s Phase 2 Clinical Trial
Reduced hospital stays with more patients discharged to home when treated with RNS60 Results presented during oral presentation at the American Academy of Neurology 2025 Annual Meeting TACOMA, Wash., April 9, 2025 /PRNewswire/ — Revalesio, a clinical-stage pharmaceutical company…
Allegheny Health Network Neurosurgeon Performs the Region’s First Vagus Nerve Stimulation Procedure to Enhance Stroke Recovery
Innovative Therapy Helps Wexford Stroke Survivor Regain Hand Function and Return to Playing Guitar B-ROLL AND INTERVIEWS: https://f.io/lpCCNeXD VIDEO of Vivistim® Paired VNS System: microtransponder | Showpad PITTSBURGH, Pa., April 3, 2025 /PRNewswire/ — Stroke is a potentially…
Enspire DBS Therapy Announces the First Patient Implanted in the Second Center for RESTORE, a Multicenter Pivotal Phase 2/3 Clinical Trial for the Treatment of Arm Weakness and Reduced Function after Stroke
The first patient implanted at Brown University Health marks the expansion of the study to multiple clinical sites RESTORE aims to generate the data necessary to demonstrate the long-term safety and efficacy of DBS+Rehab in stroke patients to support marketing approval CLEVELAND, March 4,…



